FDA Approves Merck’s Gardasil Vaccine To Prevent Cervical Cancer.
FDA Roundup: Public Citizen Uses Logic of FDA’s Critical Path to Challenge Decision On Anti-Obesity Drug.
Advocates Oppose Proposals to Market Drugs After Phase I.
ODAC Meets at ASCO, Recommends Approval Of Dasatinib For CML.
House Subcommittee Passes Bush Request for NIH, NCI Budgets.
NCI: The Times Have Been “Confusing,” Acting NCI Director Niederhuber Admits in Memo.
Trending Stories
- DOD cancer research programs face 57% funding cut in year-long continuing resolution
Pancreatic, lung, kidney cancer research programs eliminated - Karen Knudsen tells us why she took the CEO job at the Parker Institute for Cancer Immunotherapy
- Brian Druker, developer of Gleevec, eyes a new feat: Setting the Boston Marathon fundraising record
Current record: $507,000. Proceeds to go to LLS as NIH funding is slashed - Amid HHS upheaval, Bhattacharya takes the helm at NIH, Makary at FDA
Meanwhile, NASEM sounds “SOS” for health infrastructure - What Trump’s pick of RFK Jr. means for cancer: Epidemics, HPV, stunted research
Former FDA Commissioner Scott Gottlieb expresses “deep concerns” - In The Headlines: Private funding can’t replace federal funding—but it can help